HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surrogate end points in clinical trials: the case of anti-neutrophil cytoplasm antibody-associated vasculitis.

AuthorsMichael Walsh, Marcello Tonelli, David Jayne, Braden Manns
JournalJournal of nephrology (J Nephrol) 2007 Mar-Apr Vol. 20 Issue 2 Pg. 119-29 ISSN: 1121-8428 [Print] Italy
PMID17514615 (Publication Type: Journal Article, Review)
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
  • Biomarkers
Topics
  • Antibodies, Antineutrophil Cytoplasmic (immunology)
  • Biomarkers (metabolism)
  • Humans
  • Randomized Controlled Trials as Topic (trends)
  • Recurrence
  • Vasculitis (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: